SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-422009"
 

Search: onr:"swepub:oai:DiVA.org:uu-422009" > Vitamin C and survi...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Harris, Holly R.Karolinska Institutet (author)

Vitamin C and survival among women with breast cancer : A Meta-analysis

  • Article/chapterEnglish2014

Publisher, publication year, extent ...

  • ELSEVIER SCI LTD,2014
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-422009
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-422009URI
  • https://doi.org/10.1016/j.ejca.2014.02.013DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:128602372URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Background: The association between dietary vitamin C intake and breast cancer survival is inconsistent and few studies have specifically examined vitamin C supplement use among women with breast cancer. The purpose of this study was to summarise results from prospective studies on the association between vitamin C supplement use and dietary vitamin C intake and breast cancer-specific mortality and total mortality. Methods: Studies were identified using the PubMed database through February 6, 2014 and by examining the references of retrieved articles. Prospective studies were included if they reported relative risks (RR) with 95% confidence intervals (95% CIs) for at least two categories or as a continuous exposure. Random-effects models were used to combine study-specific results. Results: The ten identified studies examined vitamin C supplement use (n = 6) and dietary vitamin C intake (n = 7) and included 17,696 breast cancer cases, 2791 total deaths, and 1558 breast cancer-specific deaths. The summary RR (95% CI) for post-diagnosis vitamin C supplement use was 0.81 (95% CI 0.72-0.91) for total mortality and 0.85 (95% CI 0.74-0.99) for breast cancer-specific mortality. The summary RR for a 100 mg per day increase in dietary vitamin C intake was 0.73 (95% CI 0.59-0.89) for total mortality and 0.78 (95% CI 0.64-0.94) for breast cancer-specific mortality. Conclusion: Results from this meta-analysis suggest that post-diagnosis vitamin C supplement use may be associated with a reduced risk of mortality. Dietary vitamin C intake was also statistically significantly associated with a reduced risk of total mortality and breast cancer-specific mortality. (C) 2014 Elsevier Ltd. All rights reserved.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Orsini, NicolaKarolinska Institutet (author)
  • Wolk, AlicjaKarolinska Institutet (author)
  • Karolinska Institutet (creator_code:org_t)

Related titles

  • In:European Journal of Cancer: ELSEVIER SCI LTD50:7, s. 1223-12310959-80491879-0852

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Find more in SwePub

By the author/editor
Harris, Holly R.
Orsini, Nicola
Wolk, Alicja
About the subject
MEDICAL AND HEALTH SCIENCES
MEDICAL AND HEAL ...
and Clinical Medicin ...
and Cancer and Oncol ...
Articles in the publication
European Journal ...
By the university
Uppsala University
Karolinska Institutet

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view